Table 3 Total AIDS spending and HIV M&E spending as a percent of total AIDS spending for low- and middle-income countries (n =43), 2007–2010
From: A decade of investments in monitoring the HIV epidemic: how far have we come? A descriptive analysis
| Â | 2007 | 2008 | 2009 | 2010 | ||||
|---|---|---|---|---|---|---|---|---|
| Â | Total in $1,000 USD | Â | Total in $1,000 USD | Â | Total in $1,000 USD | Â | Total in $1,000 USD | Â |
Total AIDS spending | ||||||||
All LMICs | 2,671,854 | Â | 3,447,988 | Â | 3,486,981 | Â | 3,905,516 | Â |
High-burden LMICs | 1,841,206 | Â | 2,423,261 | Â | 2,464,152 | Â | 2,775,669 | Â |
Other LMICs | 337,539 | Â | 426,205.42 | Â | 410,692.46 | Â | 469,596 | Â |
M&E | Total in $1,000 USD | % | Total in $1,000 USD | % | Total in $1,000 USD | % | Total in $1,000 USD | % |
All LMICs | 31,126 | 1.16% | 45,547 | 1.32% | 45,143 | 1.29% | 53,952 | 1.38% |
High-burden LMICs | 19,627 | 1.07% | 31,442 | 1.30% | 35,578 | 1.44% | 38,993 | 1.40% |
Other LMICs | 4,285 | 1.27% | 5,935 | 1.39% | 5,389 | 1.31% | 6,953 | 1.48% |
M&E+ | Total in $1,000 USD | % | Total in $1,000 USD | % | Total in $1,000 USD | % | Total in $1,000 USD | % |
All LMICs | 41,413 | 1.55% | 54,409 | 1.58% | 59,811 | 1.72% | 74,738 | 1.91% |
High-burden LMICs | 22,051 | 1.20% | 36,168 | 1.49% | 39,052 | 1.58% | 42,889 | 1.55% |
Other LMICs | 6,820 | 2.02% | 8,479 | 1.99% | 10,792 | 2.63% | 10,160 | 2.16% |